BAXTER

DAPTOMYCIN IN SODIUM CHLORIDE

Manufacturer:

BAXTER

Daptomycin In Sodium Chloride HCPCS:

J0874

HCPCS Code Descriptor:

Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg

Category:

J Code

Daptomycin In Sodium Chloride NDCs:

00338-0714-24, 00338-0712-24, 00338-0718-12, 00338-0716-12

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Daptomycin In Sodium Chloride:

DAPTOMYCIN IN SODIUM CHLORIDE is an antibiotic drug manufactured by Baxter and administered via the intravenous route of administration. The J Code: J0874 is aligned to the drug DAPTOMYCIN IN SODIUM CHLORIDE.

ACCESS PRICING AND MORE BY REGISTERING

J0874 Added Date:

October 1, 2023

J0874 Effective Date:

October 1, 2023

J0874 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Daptomycin In Sodium Chloride billing and coding information.
Our team did not identify a source for Daptomycin In Sodium Chloride patient assistance information. Please reach out to our team if you feel that this is a mistake.
DAPTOMYCIN IN SODIUM CHLORIDE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for DAPTOMYCIN IN SODIUM CHLORIDE. Please check back in a few weeks.